Thank you. Again, right off the product information leaflet, under elderly, it says no clinical data are available for Arepanrix H1N1 in this age group. Also, children aged from six months to 35 months, no clinical data available for influenza vaccines with ASO3 in this age group. So, Mr. Speaker, those are what is confusing to me and confusing to people.

I know I don’t have much time here, so I’d like to ask the Minister another question. In their H1N1 Slow the Spread information pamphlet that they have, they say the adjuvant in Canada’s H1N1 vaccine is made up of natural ingredients such as water, oil and vitamin E, which, yes, that’s in there. But, Mr. Speaker, there’s also something in there call Thimerosal, which contains mercury. Now that’s not in the information, Mr. Speaker.

Again, I think we just have to be upfront with people about what’s in the vaccine and how it’s been tested, because according to the information, like I said, right off of Health Canada’s website, this vaccine has not been clinically tested in its form that we’re administering it in. Thank you.